Find your next paid study

Actual pay is set by the research site.

Kathryn UnruhNCT06826326

Gastrointestinal CancerGynecologic CancerAdvanced Cancer

BOLSTER: Strengthening Patient and Caregiver Supports in Advanced Gynecologic and Gastrointestinal Cancers

This research study is evaluating a new program called Building Out Lifelines for Safety, Trust, Empowerment, and Renewal or (BOLSTER), which was designed to s…

Dana-Farber Cancer InstituteNCT06936878

~$10 – $1,125

Actual pay is set by the research site.

Implementation ScienceInformed ConsentNeonatal Screening

Implementing a Novel Consent Process for Biospecimen Research After Newborn Screening in Hospitals Serving Diverse Patients

The purpose of this study is to implement an electronic consent education process for the retention and research use of residual dried bloodspots at four hospi…

~$10 – $1,125

Actual pay is set by the research site.

Erin RothwellNCT06192511

An Augmented Reality Based System for Neglect Detection, Assessment, and Rehabilitation

The aim of this phase is to examine the feasibility and acceptability of the Augmented Reality (AR)-based and electroencephalography (EEG)-based neglect detect…

Stroke

University of PittsburghNCT04187131

~$10 – $750

Actual pay is set by the research site.

Phase 3

A Multicenter, Open-label, Extension Study to Evaluate the Long-term Safety and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine With or Without Aura in Children and Adolescents (Ages 6-17)

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting…

Migraine

Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm

~$50 – $2,250

Actual pay is set by the research site.

AbbVieNCT05127954

Phase 1

A Molecularly Driven Phase 1b Dose Escalation and Dose Expansion Study of the DNA-PK Inhibitor Peposertib (M3814) in Combination With the ATR Inhibitor Tuvusertib (M1774)

This phase I trial tests the safety, side effects and best dose of peposertib (M3814) in combination with tuvusertib (M1774) in treating patients with solid tu…

National Cancer Institute (NCI)NCT05687136

~$150 – $2,700

Actual pay is set by the research site.

Oropharyngeal Squamous Cell CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma

Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma (REDUCE-30)

This is a single-arm, phase II study that is designed to investigate nodal and primary tumor CTV dose de-escalation (30 Gy) in HPV positive oropharyngeal cance…

Actual pay is set by the research site.

Sara MedekNCT07497607

Phase II Open-label, Multi-center Study of Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma (mUM) With Integrated Circulating Tumor DNA (ctDNA) Biomarker (TARGET-tebe)

This is a phase II open-label, single-arm, multi-center study of tebentafusp in HLA- A\*0201 positive previously untreated (1L) untreated metastatic uveal mela…

Uveal Melanoma

Actual pay is set by the research site.

Diwakar DavarNCT06070012

Mitigation of Acute Voice Changes Follwing Rigorous Voice Use

The Effect of Fish Oil Supplementation on the Voice of Female Professional Voice Users

The design of the study allows us to test if there are differences in a battery of voice assessments (Aim 1) and biomarkers from vocal fold secretions (Aim 2) …

Baylor UniversityNCT07800702

~$10 – $750

Actual pay is set by the research site.

Phase 1

Erector Spinae Plane Block for Patients With Intractable Abdominal Pain in the Emergency Department: A Pilot Study

Currently, the standard treatment of nonsurgical abdominal pain in the Emergency Department (ED) includes narcotic pain medication. This can be addictive and c…

Erector Spinae Plane Block

University of California, IrvineNCT07826936

~$150 – $3,000

Actual pay is set by the research site.

Diabetes Mellitus, Type 2Pre-diabetes

Tau Positron Emission Tomography (PET) Imaging in the Northern Manhattan Study of Metabolism and Mind (NOMEM) With 18F-MK6240.

This is a single center brain Positron Emission Tomography (PET) study of 18F-MK-6240. Eligible participants are persons from Northern Manhattan who self-ident…

Columbia UniversityNCT03389100

~$75 – $2,000

Actual pay is set by the research site.

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

This is a randomized, double-blind, placebo-controlled basket trial evaluating mifomelatide (TCMCB07) administered daily by subcutaneous (SC) injection in up t…

Cancer Weight Loss